Today, the APPG for First Do No Harm held a meeting with Nadine Dorries MP, the Minister for Patient Safety, Suicide Prevention and Mental Health. View a recording of the session below or please click here.
The Department of Health & Social Care (DHSC) has announced its intention to appoint 15 people to a patient reference group. This group will work with DHSC as it develops and implements the Government’s response to First Do No Harm.
The following information has been copied from the website of Traverse , an independent research and engagement consultancy that has been appointed by DHSC to recruit this patient reference group:
If you require any further information about this patient reference group, please email IMMDSRPatientGroup@traverse.ltd.
What will the group be doing?
- Meeting online to share experiences, ideas and recommendations
- Helping to shape the Government’s response to the IMMDS Review, ensuring that patient voices are heard in the process
- Providing advice, challenge, and scrutiny as the Government implements its response
We are looking for people who:
- Have a personal experience of or understand the context of the IMMDS Review
- Are committed to improving the experience of patients
- Want to engage with others on the group and DHSC representatives to support the development and implementation of the Government’s response to the IMMDS Review
- Can consider complex and emotive issues in a balanced and sensitive way
- Have good communication skills, and want to build strong working relationships with the rest of the group
If you are interested in getting involved, please contact us at IMMDSRPatientGroup@traverse.ltd for a recruitment pack and more information on how to apply.
We’re also looking for a co-chair to support group members contribute to the group and make sure group members are heard. If you know the English healthcare system well and are comfortable working on sensitive issues, take a look at the recruitment pack to find out more about the co-chair role and how to apply.
On 26th January at 10:30am, the Minister for Patient Safety, Nadine Dorries MP will attend a virtual meeting of the APPG for First Do No Harm to provide an update on the Government’s thinking regarding the Review’s recommendations, further to the written statement released by the Department of Health and Social Care (DHSC) earlier this week.
The Minister will make an introductory statement before participating in a Q&A with Baroness Cumberlege, the Group’s officers and other parliamentarians. Patient campaigners and other interested parties are welcome to attend the meeting and to participate in the Q&A.
To register interest in attending the meeting which will be held on Zoom please contact the Group’s Secretariat at Luther Pendragon via firstname.lastname@example.org.
In an op-ed published in The Times Red Box today, and on the day the Medicines and Medical Devices Bill returns to the House of Lords, APPG Co-Chair Baroness Cumberlege restates the case for an independent Patient Safety Commissioner. The text from the article is copied below – to view the article in full click here.
Patients need a voice if we are to avoid the medical harm caused in the past
In July last year, the Independent Medicines and Medical Devices Safety Review – which I chaired — published its landmark report, First Do No Harm. It followed a two-year review of harrowing patient testimony and a large volume of other evidence concerning three medical interventions: Primodos, sodium valproate and pelvic mesh.
Last month, Jeremy Hunt – who commissioned the review as health secretary – joined me in launching an all-party parliamentary group whose aim is to achieve the implementation of the review’s recommendations. At our first meeting before Christmas we were joined not only by a wide array of parliamentarians but by more than one hundred patient group representatives. Their knowledge, passion and dignity in the face of great suffering is inspirational.
Over the course of our work, my team and I observed a healthcare system that was disjointed, unresponsive and defensive. Our report set out in no uncertain terms how the system does not adequately recognise that patients are its raison d’être, and that it has failed to listen to their concerns and when, belatedly, it has decided to act it has too often moved glacially.
One of the nine wide-ranging and radical recommendations we made was to establish in statute an independent patient safety commissioner. This person would be the patients’ port of call, their listener and advocate, who holds the system to account, monitors trends, and demands action. It is our hope that this commissioner would be the golden thread tying this fragmented system together.
To see the benefits this new, independent and powerful voice brings, one only has to look at the work of existing commissioners in different policy areas in England. Anne Longfield, the children’s commissioner, for example, has spent the past year highlighting the dreadful impact of the pandemic on children’s safety and development, while Dame Vera Baird, the victims’ commissioner and Nicole Jacobs, the domestic abuse commissioner, have both lent their weight to the campaign to introduce a crime of non-fatal strangulation so that domestic abusers face more punitive sentences. This is, unquestionably, valuable work indeed.
In respect of medicines and medical devices, a truly independent patient safety commissioner would do similar: listen to patients and their families; look for trends and patterns that give rise to safety concerns; and require the healthcare system to act to reduce or remove the risk of avoidable harm. Had a patient safety commissioner existed before now, my team and I are in no doubt that much suffering could have been avoided.
I am pleased to say that the government has now accepted the need for a patient safety commissioner for England. It has brought forward its own amendment to the Medicines and Medical Devices Bill, which is being considered in the House of Lords today. I hope it will swiftly become law.
This is a topic upon which the government has listened and acted, and I thank them for it, but a full response to the review’s report is still outstanding some six months after publication. Action is urgently needed to ensure we help those who have already suffered and reduce the risk of harm to patients in future.
Baroness Cumberlege is a Conservative peer and was chairwoman of the Independent Medicines and Medical Devices Safety Review (2017-2020)
Today, the Minister for Patient Safety, Nadine Dorries MP, provided a written update on the Government’s response to the publication of ‘First Do No Harm’. The Group will be considering this over the coming days.
To view the article in full click here.
In a Letter to the Editor published in The Times today, APPG Co-Chair Baroness Cumberlege argues in favour of the work of the Independent Medicines and Medical Devices Safety Review and its report, First Do No Harm. The text from the letter is copied below – to view the article in full click here.
MRS MAY’S INQUIRIES
Sir, It was unreasonable to suggest in your news report that none of the inquiries set up by Theresa May’s administration has completed a final report (“£300m bill for May public inquiries before any of them produce report”, Jan 1). I was commissioned by Mrs May to investigate the harm done to women by two medications taken during pregnancy, and the life- changing pain experienced by many women fitted with vaginal mesh. Our report “First Do No Harm” cost about £1 million — modest for two and a half years’ work by a small team.
Of the nine recommendations that we made, one, an apology, has been achieved; a second recommendation, the appointment of a patients’ safety commissioner, is promised; vaginal mesh is now seldom used; and a First Do No Harm all-party parliamentary group has been established with private funding, to fulfil the other recommendations and bring justice to those harmed women.
Inquiries are only as good as the change for the better that results from their work. We are getting there.
House of Lords
This morning, Baroness Cumberlege led a virtual event to launch the All-Party Parliamentary Group for First Do No Harm, in which she introduced the Group, restated the case for the implementation of the recommendations in First Do No Harm and provided an update on recent developments regarding the Review’s recommendations.
The text of her remarks can be accessed here – this text should be checked against delivery.
On Wednesday, 16th December at 10:30 the APPG held a formal, virtual launch via Zoom. Baroness Cumberlege provided an update on the Group’s activity and answered questions from attendees. A note of the meeting is available here.
16, November 2020: Baroness Cumberlege and Jeremy Hunt MP have today launched an All-Party Parliamentary Group (APPG) to raise awareness of and build support for the recommendations in First Do No Harm, the landmark report of the Independent Medicines and Medical Devices Safety (IMMDS) Review.
The publication of First Do No Harm in July 2020marked the culmination of a Review that, over two years, heard harrowing patient testimony and received a large volume of other evidence concerning three medical interventions: Primodos, sodium valproate and pelvic mesh. The IMMDS Review was Chaired by Baroness Cumberlege and commissioned by Jeremy Hunt MP in February 2018, during his tenure as Secretary of State for Health and Social Care.
First Do No Harm set out nine major recommendations to bring much-needed help and support to those who have suffered as a result of these interventions, and to reduce the risk of avoidable harm from medicines and medical devices in the future. There is a widespread consensus in favour of its recommendations, among all the patient groups concerned with the issues and among royal colleges, professional bodies, public institutions and others.
The APPG for First Do No Harm (APPGFDNH) will campaign to raise awareness of and build support for the implementation of the nine recommendations, eight of which remain outstanding after fulsome apologies were given by the Secretary of State for Health and Minister for Patient Safety on the day First Do No Harm was published.
Positive discussions have been had with the Government on the need for a Patient Safety Commissioner for England, which it has now accepted and intends to bring forward as an amendment to the Medicines and Medical Devices Bill at the Report Stage. APPGFDNH is encouraged by this progress and will work to ensure the Commissioner is truly independent.
Baroness Cumberlege, Co-Chair of the All-Party Parliamentary Group for First Do No Harm, said:
“While it is welcome that the Government has so far addressed one of the nine recommendations, when First Do No Harm was published in July we had hoped that more progress would have been made by now. We understand that its recommendations were indeed wide-ranging , but the scale of the suffering the Review observed over its two years of work means that nothing short of profound change is urgently required.
“The Government has the power to harness the consensus in favour of the report’s recommendations and deliver change for those patients affected by the issues the Review examined, as well as for future patients. Members of the newly-constituted APPG for First Do No Harm will be the first to express our gratitude when they do.”
The Rt Hon Jeremy Hunt MP, Co-Chair of the All-Party Parliamentary Group for First Do No Harm, said:
“When I commissioned the Independent Medicines and Medical Devices Safety Review in 2018 it was already clear that our healthcare system was still too closed, defensive and focused on blame rather than learning lessons.
“The case for change has been powerfully made in First Do No Harm. There is literally nothing more tragic than a death or disability that didn’t need to happen, so the recommendations are a matter of great urgency to ensure other families are spared similar heartache. This APPG will work relentlessly to make sure this seminal report is implemented in full and without delay: lessons must be learnt once and for all.”
The Group’s officers include parliamentarians with a track record of campaigning for patient safety, as well as the Chairs of the APPGs on the interventions covered by the IMMDS Review: Emma Hardy MP, APPG on Surgical Mesh; Cat Smith MP, APPG for Valproate and other Anti-Epileptic Drugs in Pregnancy; and Yasmin Qureshi MP, APPG on Hormone Pregnancy Tests. Its full list of offices is as follows:
- Baroness Cumberlege CBE DL, Co-Chair
- The Rt Hon Jeremy Hunt MP, Co-Chair
- Lord O’Shaughnessy, Vice-Chair
- Lord Patel, Vice-Chair
- Lord Hunt of Kings Heath, Vice-Chair
- Sharon Hodgson MP, Vice-Chair
- Emma Hardy MP, Vice-Chair
- Cat Smith MP, Vice-Chair
- Yasmin Qureshi MP, Vice-Chair
The Group was constituted in September and has been registered with the parliamentary authorities. It will announce its programme of activity in due course. The Minister for Patient Safety, Nadine Dorries MP, has been invited to the Group’s first public meeting to provide an update on the Government’s thought process and activity since the report’s publication, and to share her insight regarding next steps.
The IMMDS Review’s major recommendations include:
- That the Government immediately issues a fulsome apology on behalf of the healthcare system to the families affected by Primodos, sodium valproate and pelvic mesh.
- That a Patient Safety Commissioner is appointed. This person would be the patients’ port of call, listener and advocate, who holds the system to account, monitors trends, and demands action.
- Separate schemes should be set up for Hormone Pregnancy Tests, valproate and pelvic mesh to meet the cost of providing additional care and support to those who have experienced avoidable harm and are eligible to claim.
- A Redress Agency for those harmed by medicines and medical devices in future should be established.
- The establishment of two types of specialist centres, located regionally – for mesh, and separately for those affected by medications taken during pregnancy.
- The regulator of medicines and medical devices, the MHRA, needs to put patients at the heart of its activity, and to overhaul adverse event reporting and medical device regulation.
- That a central database should be created by collecting key details including the patient, the implanted device, and the surgeon.
- That the register of the General Medical Council (GMC) should be expanded to include a list of financial and non-pecuniary interests for all doctors, as well as doctors’ clinical interests and specialisms.
- Finally, that the Government immediately sets up a task force to implement the Review’s recommendations.
For more information visit the Group’s website at FirstDoNoHarmAPPG.org.uk or contact the Secretariat on 02076189189, 07947477460 or email@example.com.
You can visit the Independent Medicines and Medical Devices Safety Review’s website to read more from Baroness Cumberlege about the Review’s work and its findings here https://www.immdsreview.org.uk/